Metabolic & Cardiometabolic
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 LLY | Eli Lilly & Co. | $0.8t | $871.50 | -1.4% | 2.7M |
 AZN | AstraZeneca PLC | $300.7b | $188.23 | -0.8% | 2.1M |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $11.6b | $520.05 | +1.5% | 216.0K |
 PTGX | Protagonist Therapeutics, Inc | $6.4b | $98.43 | -1.6% | 994.7K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.0b | $52.95 | +0.1% | 4.2M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $3.5b | $43.68 | +2.1% | 1.3M |
 VKTX | Viking Therapeutics, Inc | $3.5b | $33.00 | +0.8% | 1.5M |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.4b | $30.43 | +2.4% | 1.3M |
 TVTX | Travere Therapeutics, Inc. Common Stock | $2.6b | $40.84 | +0.8% | 1.0M |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $1.9b | $27.00 | -1.9% | 836.9K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.4b | $26.47 | +2.6% | 588.0K |
 MBX | MBX Biosciences, Inc. Common Stock | $1.3b | $31.98 | +0.1% | 385.7K |
 SEPN | Septerna, Inc. Common Stock | $1.0b | $25.07 | +1.6% | 370.8K |
 MNKD | Mannkind Corporation | $0.7b | $2.64 | -2.2% | 3.9M |
 BIOA | BioAge Labs, Inc. Common Stock | $0.7b | $18.03 | +5.7% | 348.8K |
 ESPR | Esperion Therapeutics, Inc. | $0.7b | $1.90 | -0.5% | 7.3M |
 LXRX | Lexicon Pharmaceuticals, Inc. | $0.6b | $1.69 | +0.6% | 1.9M |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.6b | $7.65 | +2.8% | 32.1K |
 ALT | Altimmune, Inc. Common Stock | $374.7m | $2.80 | -1.8% | 5.9M |
 RZLT | Rezolute, Inc. Common Stock (NV) | $272.7m | $3.31 | +6.6% | 3.9M |
 TENX | Tenax Therapeutics, Inc. | $240.9m | $15.06 | +5.3% | 2.0M |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $148.3m | $8.20 | +39.9% | 49.4M |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $144.5m | $29.63 | -9.6% | 104.6K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $136.2m | $1.39 | -0.7% | 294.1K |
 ORMP | Oramed Pharmaceuticals Inc. | $130.6m | $4.11 | +6.6% | 428.1K |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $118.8m | $1.87 | -1.1% | 678.7K |
 BMEA | Biomea Fusion, Inc. Common Stock | $95.4m | $1.74 | -7.9% | 2.5M |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $79.4m | $5.51 | +2.3% | 124.6K |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $79.4m | $1.40 | +3.7% | 448.9K |
 GUTS | Fractyl Health, Inc. Common Stock | $67.7m | $0.66 | +5.8% | 2.0M |
 LPCN | Lipocine Inc. | $55.3m | $2.38 | -1.9% | 210.8K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $40.6m | $6.52 | +1.9% | 140.2K |
 VERU | Veru Inc. | $34.2m | $2.33 | +0.4% | 47.7K |
 SKYE | Skye Bioscience, Inc. Common Stock | $19.8m | $1.04 | +7.7% | 645.1K |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $13.8m | $0.43 | -1.1% | 81.5K |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $9.9m | $5.83 | +6.0% | 46.2K |
 NCEL | NewcelX Ltd. Ordinary Shares | $8.6m | $3.85 | -17.4% | 114.0K |
 GRDX | GridAI Technologies Corp. Common Stock | $6.8m | $2.27 | 0.0% | 110.1K |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $6.3m | $2.73 | -1.3% | 10.2K |
 MTVA | MetaVia Inc. Common Stock | $6.0m | $1.55 | -0.3% | 84.1K |
 GLMD | Galmed Pharmaceuticals Ltd. | $3.1m | $0.63 | +0.4% | 92.3K |
 ELAB | PMGC Holdings Inc. Common Stock | $1.9m | $2.55 | +2.4% | 537.4K |